Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 2/20 | 0.33 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.31 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5654011 | 0.90 | CSNK2A2 (0.36) | CSNK2A2CSNK2BCSNK2A1MEN1KMT2A | |
| SCHEMBL5655483 | 0.86 | CSNK2A2 (0.36) | CSNK2A2CSNK2BCSNK2A1MEN1KMT2A | |
| SCHEMBL5653106 | 0.84 | POLB (0.42) | MEN1KMT2AMAPTPOLBPKM | |
| SCHEMBL5654798 | 0.84 | MEN1 (0.36) | CSNK2A2CSNK2BCSNK2A1MEN1KMT2A | |
| SCHEMBL5653660 | 0.81 | SMN1; SMN2 (0.42) | MEN1KMT2AMAPTLMNA | |
| SCHEMBL5666340 | 0.80 | NLRP3 (0.39) | MEN1KMT2AMAPTPOLBCACNA1F | |
| SCHEMBL5654738 | 0.79 | ELANE (0.36) | MEN1KMT2ALMNACACNA1FABCB1 | |
| SCHEMBL5653859 | 0.78 | L3MBTL1 (0.38) | MEN1KMT2AMAPTLMNA | |
| SCHEMBL5655563 | 0.78 | CYP2D6 (0.40) | MEN1KMT2AMAPTPOLBCACNA1F | |
| SCHEMBL5655350 | 0.77 | TGM2 (0.34) | MEN1KMT2AMAPTPKMCACNA1F |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070259948-A1 | Compounds with antifungal properties and process thereof | FDC LIMITED (IN) | 2007-11-08 | — | — | US | disclosed |
| US-20070259948-A1 | Compounds with antifungal properties and process thereof | FDC LIMITED (IN) | 2007-11-08 | — | — | US | disclosed |
| US-20070259948-A1 | Compounds with antifungal properties and process thereof | FDC LIMITED (IN) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259948-A1 | Compounds with antifungal properties and process thereof | ADH5, GK, AKR1C3 | CSNK2A2 2506/4885CSNK2B 2393/4885CSNK2A1 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.